Epimedin B exerts neuroprotective effect against MPTP-induced mouse model of Parkinson's disease: GPER as a potential target
Authors:
Open Access
- 4 November 2022
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 156, 113955
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31871144)
- Natural Science Foundation of Shandong Province (ZR2019MH018)
This publication has 43 references indexed in Scilit:
- Estrogen biology: New insights into GPER function and clinical opportunitiesMolecular and Cellular Endocrinology, 2014
- Estrogen Receptors, the Hippocampus, and MemoryThe Neuroscientist, 2014
- Implication of GPER1 in neuroprotection in a mouse model of Parkinson's diseaseNeurobiology of Aging, 2013
- Herba epimedii flavonoids suppress osteoclastic differentiation and bone resorption by inducing G2/M arrest and apoptosisBiochimie, 2012
- Neuroprotection and Estrogen ReceptorsNeuroendocrinology, 2012
- The G-protein-coupled estrogen receptor GPER in health and diseaseNature Reviews Endocrinology, 2011
- Herba Epimedii: Anti-Oxidative Properties and Its Medical ImplicationsMolecules, 2010
- Total flavonoid fraction of the Herba epimedii extract suppresses urinary calcium excretion and improves bone properties in ovariectomised miceBritish Journal of Nutrition, 2010
- Endoplasmic reticulum and mitochondria interplay mediates apoptotic cell death: Relevance to Parkinson's diseaseNeurochemistry International, 2009
- Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's diseaseNeuroscience Research, 2008